Palo Alto Investors »

Akari Therapeutics Plc Sponsored shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $148k 146k 1.01
2025-06-30 $171k 146k 1.17
2025-03-31 $181k 146k 1.24
2024-12-31 $178k 146k 1.22

More positions owned by Palo Alto Investors

Insmed (INSM)
Ptc Therapeutics I (PTCT)
ACADIA Pharmaceuticals (ACAD)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Biogen Sponsored Ads (BIIB)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Iovance Biotherapeutics Com New (IOVA)
Novocure Ltd ord (NVCR)
Dyne Therapeutics Sponsored Ads (DYN)
Disc Medicine (IRON)
Alnylam Pharmaceuticals (ALNY)
Gossamer Bio (GOSS)
Prothena Corp Com Cl A (PRTA)

View all positions for Palo Alto Investors

Top funds holding Akari Therapeutics Plc Sponsored

Cresset Asset Management
Palo Alto Investors
HighTower Advisors
Omnia Family Wealth
HPM Partners
Virtu Financial
Two Sigma Securities
Independent Advisor Alliance
Accent Capital Management
Goss Wealth Management
UBS Group
Truvestments Capital
EverSource Wealth Advisors
Cornerstone Planning Group
Morgan Stanley

View all funds holding Akari Therapeutics Plc Sponsored